Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:51 AM
Ignite Modification Date:
2025-12-24 @ 11:51 AM
NCT ID:
NCT02697461
Eligibility Criteria:
Inclusion Criteria:
Healthy participants
* Aged 18-50
* All subjects will be physically active: Participating in some form of physical activity for at least 20 min per day, three times per week.
* All subjects will have no history of ankle injury.
LAS participants
* Aged 18-50
* All subjects with a history of ankle sprains, no lingering symptoms or disability, not actively receiving treatment for their ankle sprain
* All subjects will be physically active: Participating in some form of physical activity for at least 20 min per day, three times per week.
CAI participants
* Aged 18-50
* CAI with a history of recurrent ankle sprains, with the first sprain occurring longer than 12 months ago. They will have lingering symptoms, and disability, but not actively receiving treatment for their CAI
* All subjects will be physically active: Participating in some form of physical activity for at least 20 min per day, three times per week.
Exclusion Criteria:
* Neurological or vestibular disorders affecting balance
* Currently seeking medical care for LAS/CAI
* History of prior ankle surgery
* History of ankle or foot fracture
* Diabetes mellitus
* Current self-reported disability due to lower extremity pathology that may adversely affect neuromuscular function
* Lumbosacral radiculopathy
* Soft tissue disorders including Marfan's syndrome and Ehlers-Dandros syndrome
* Absolute contraindications to manual therapy
* Pregnancy
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
50 Years
Study:
NCT02697461
Study Brief:
Protocol Section:
NCT02697461